You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Business

Genzyme drug for treating thyroid cancer is approved for wider use in Europe

Genzyme, the Cambridge biotechnology company now owned by French drug maker Sanofi SA, said that a drug used in treating thyroid cancer has been approved for wider use in Europe.

The drug is Thyrogen, and it has been approved for use in the management of patients with thyroid cancer in the United States since 1998. It has also been approved for use in Europe.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week